CABOTEGRAVIR

Clinical trials for CABOTEGRAVIR explained in plain language.

Never miss a new study

Get alerted when new CABOTEGRAVIR trials appear

Sign up with your email to follow new studies for CABOTEGRAVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New Long-Acting HIV shots aim to keep virus in check

Disease control Not yet recruiting

This study looks at how well a long-acting HIV treatment works. It combines two drugs, cabotegravir and lenacapavir, given as shots. The goal is to see if the treatment keeps the virus under control and is safe. About 50 adults with HIV who are already on or starting this combo w…

Matched conditions: CABOTEGRAVIR

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control

Last updated May 17, 2026 06:45 UTC

CABOTEGRAVIR

Get alerted when new CABOTEGRAVIR trials appear

New Long-Acting HIV shots aim to keep virus in check